18 Matching Annotations
  1. Nov 2023
  2. Feb 2023
  3. Oct 2022
  4. Jun 2022
  5. Nov 2021
    1. RRID:AB_312899

      DOI: 10.1016/j.devcel.2021.11.006

      Resource: (BioLegend Cat# 102404, RRID:AB_312899)

      Curator: @scibot

      SciCrunch record: RRID:AB_312899


      What is this?

  6. Aug 2021
    1. RRID:AB_312899

      DOI: 10.1016/j.stem.2021.07.001

      Resource: (BioLegend Cat# 102404, RRID:AB_312899)

      Curator: @scibot

      SciCrunch record: RRID:AB_312899


      What is this?

  7. Jul 2021
  8. Jun 2021
    1. RRID:AB_312899

      DOI: 10.1016/j.isci.2021.102551

      Resource: (BioLegend Cat# 102404, RRID:AB_312899)

      Curator: @scibot

      SciCrunch record: RRID:AB_312899


      What is this?

  9. Feb 2021
  10. Sep 2020
  11. Jan 2020
    1. RRID:AB_312899

      DOI: 10.1016/j.immuni.2019.02.002

      Resource: (BioLegend Cat# 102404, RRID:AB_312899)

      Curator: @ethanbadger

      SciCrunch record: RRID:AB_312899


      What is this?

  12. Nov 2018
  13. Nov 2017
    1. Before adding the fluorescently labeled antibodies, Fc-receptors were blocked with anti-CD16/CD32 (Pharmingen) antibodies was performed. Mammary epithelial cells were labeled with antibodies directed against CD24 (Pharmingen #553261), CD49f (Pharmingen #551129) and CD61 (eBioscience #11-0622-82). Non-epithelial cells were excluded using antibodies directed against CD45 (BD #553078), CD31 (BioLegend #102404)

      Curator: @bandrow

      Curator note: BioLegend Cat# 102404, RRID:AB_312899

      Resource used:

      (BioLegend Cat# 102404, RRID:AB_312899)

      SciCrunch record: RRID:AB_312899

      Alternate resolvers: SciCrunch xml N2T identifiers.org


      What is this?